| Dr Marco Antonio Caceres Sr, MD | |
|
244 Smith Church Rd, Roanoke Rapids, NC 27870-4956 | |
| (252) 535-2350 | |
| Not Available |
| Full Name | Dr Marco Antonio Caceres Sr |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Undersea And Hyperbaric Medicine |
| Location | 244 Smith Church Rd, Roanoke Rapids, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679778005 | NPI | - | NPPES |
| 8920639 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0011X | Preventive Medicine - Undersea And Hyperbaric Medicine | 19676 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marco Antonio Caceres Sr, MD 110 Walter Ave, Roanoke Rapids, NC 27870-1609 Ph: (252) 537-7084 | Dr Marco Antonio Caceres Sr, MD 244 Smith Church Rd, Roanoke Rapids, NC 27870-4956 Ph: (252) 535-2350 |
News Archive
University of Illinois engineers are bringing a touch of color to glucose monitoring. The researchers developed a new continuous glucose monitoring material that changes color as glucose levels fluctuate, and the wavelength shift is so precise that doctors and patients may be able to use it for automatic insulin dosing - something not possible using current point measurements like test strips.
A randomized trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic colorectal cancer, researchers report at the ESMO Asia 2017 Congress.
A new study by researchers at the University of Alabama at Birmingham (UAB) School of Public Health shows that obesity research may be misrepresented by scientists operating with particular biases on topics related to weight, nutrition and the food industry.
Scientists from the Johns Hopkins University School of Medicine, USA, have recently developed an Antibody Display technology by grafting the second extracellular domain of tetraspanin12 (Tspan12EC2) and the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein on the heavy chain complementarity-determining region 3 (CDR3).
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
› Verified 9 days ago